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Abstract 
Treatment outcome has become increasingly the subject of focus in the area of 
psychological research.  Often contested has been the ever widening debate over the 
efficacy of medication treatment versus psychotherapy.  Using a sample of 62 adults 
diagnosed with Major Depression, this study compared the treatment outcome of those 
receiving just medication versus those receiving medication and psychotherapy.  The data 
were collected for subjects receiving treatment over a six month period.  The study 
examined whether those receiving medication and therapy experienced a higher degree of 
improvement as measured by the Basis-32 symptom identification scale which was 
completed by all participants both pre-treatment and after six months of treatment.  
Results suggested that overall the subjects receiving both medication and psychotherapy  
compared with those receiving medication only scored significantly lower on the 
Basis-32 indicating a significantly higher degree of improvement, including, a 
significantly higher degree of improvement with depressive symptoms.    
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CHAPTER ONE 
INTRODUCTION 
PURPOSE OF THE STUDY 
    The purpose of this research was to measure the outcome that therapy offers when 
combined with medication in the treatment of depression.  Improvement was assessed 
using the BASIS-32 symptom identification scale (Basis-32) which is completed at the 
onset of treatment and at the end of six months.  This research is an attempt to support the 
notion that the inclusion of both medication and therapy will provide the best treatment 
option for Major Depression. 
Availability of Information: 
    There is a significant amount of research supporting therapy as an effective 
intervention for the treatment of depression (Paykel, et al., 1999).  There is also a 
significant amount of research supporting that anti-depressant medication is an effective 
treatment intervention (Elkin, et al., 1989).  There have been numerous studies comparing 
the effectiveness of different types of therapy, as well as, different types of medication 
(Shea, et al., 1992).  Recently, there has been an increase in the study of combining 
psychotherapy and medication in the treatment of depression (Moyer, 2004).                    
Research has shown that compliance issue arise during the treatment process, such as, 
during the initial six weeks which is approximately how long it takes for medication to 
reach a therapeutic response.  Also, during remission when patients feel well enough to 
attempt to discontinue medication.  It is here where therapy can be both supporting and 
beneficial (DeRubeis, et al, 2002).    
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Need for the Study:     
    The primary focus of this research is to determine if therapy positively influences 
treatment outcome.  There are critical phases during the treatment process for depression 
that are connected to treatment outcome and are vital during the course of treatment in 
order for patients to be least distressed and most comfortable throughout the  
process (Spigset & Bjorn, 1999).  This research will determine if therapy combined with 
medication versus just medication will improve treatment outcome.  This being 
established, perhaps a closer look at the critical phases of treatment will show that some 
modes of psychotherapy may be more effective than others.  The initial six weeks of 
treatment is a critical phase in the treatment process.  It is here where patients are initially 
assessed and often prescribed medication.  Most Seratonin Specific Reuptake Inhibitors 
(SSRIs) take six to eight weeks before patients notice improvement with their symptoms.  
Some research indicates that therapy is important during this phase of treatment (Paykel, 
et al., 1999).  Without support during this period, many patients are likely to drop out of 
treatment or to suffer unnecessarily.  Also, toward the end of treatment may be 
considered another critical phase when patients may want to titrate off of their 
medications and try to move on with their lives without medication.  Often during this 
period cognitive therapy can be beneficial (Paykel, et al., 1999).  Helping patients rebuild 
positive thought processes in this stage is critical.  Educating patients about certain 
thought processes which encourage depressive responses versus thought process that are 
recovery centered can be taught during this stage (Paykel et al., 1999). 
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Definition of Terms: 
      Psychotherapy cannot be defined with any precision.  Psychotherapy could be  
defined as a formal process of interaction between two parties, each party usually 
consisting of one person but with the possibility that there may be two or more people in 
each party.   The interaction is for the purpose of ameliorating distress in one of the two 
parties (i.e., client) relative to any of the following areas of disability or malfunction:  
cognitive functions (disorders of thinking), affective functions (suffering or emotional 
discomforts), or behavioral functions (inadequacy of behavior).  The interaction would 
require that the therapist have some theory of personality origins and development.  The 
therapist would need to posses a high level of self-understanding, and experience with 
change along with some method of treatment logically related to the theory the therapist 
has taken into practice.  Also, the therapist should possess the professional and legal 
approval to act as a therapist (Corsini, 1989).  It is important to note that some modes of 
psychotherapy may fit the definition better than others.  This definition would be more 
suited for the more non-directive psychotherapies, such as, person centered.  Whereas, 
more directive therapy, such as, behavior modification would rely less on the interaction 
and more on the actions created in treatment.   
     OMM:  Out-patient Medication Maintenance (OMM) is a community based not-for-
profit program that provides outpatient treatment for adults who are assessed to have a 
need for medication and counseling services yet do not fulfill the criteria for case 
management services which would include home visits, medication monitoring, and 
access to entitlements. The criteria for admission into the OMM program are as follows: 
A) You must be 18 years old or older. 
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B) You must carry an Axis I diagnosis which fulfills the criteria indicated in the 
Diagnostic and Statistical Manual for Mental Disorders (DSM-IV). 
C) You must be able to independently attend appointments which are prescheduled.  
D) Your treatment requires that you are in need of medication intervention. 
E)  You do not fulfill the criteria for case management or more intensive services. 
     Once an individual is admitted into the OMM program, the option of therapy is 
offered to all participants.  The therapy offered is supportive in nature but also provides 
coping strategies for patients to manage problem areas.  During therapy the client is 
encouraged to discuss experiences as related to affect, thought processes and day to day 
stressors.  In this study the therapy would be classified as “supportive therapy” initially in 
treatment with more focus on goals and objectives as treatment progresses.  Perhaps a 
more detailed review of the thought processes which may be reinforcing the depression 
and the introduction of techniques which can intervene to break patterns that may have 
developed prior to treatment can be explored once a positive and trusting relationship 
develops between the patient and therapist.  The patient’s initial assessment begins with 
seeing the psychiatrist for a comprehensive initial psychiatric evaluation which 
incorporates a history of the client’s treatment, a mental status exam and the client’s 
social history.  Past substance use related difficulties, vocational history and medical 
concerns are also part of the assessment.  Subsequent medication evaluations which are 
shorter in duration are scheduled every three months if the patient needs to be medicated.  
Patients who do not meet the criteria are referred to non-medication outpatient programs.  
All candidates complete the Basis-32 during their initial interview and at the six-month 
treatment interval. 
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CHAPTER II 
REVIEW OF RELATED RESEARCH 
    There is a significant amount of current research that indicates the potential benefits of 
medication and psychotherapy in the treatment of depression.  Some studies indicate that 
medication alone will provide the best outcome.  In 1989, the National Institute of Mental 
Health (NIMH) instituted the Treatment of Depression Collaborative Research Program.  
This was the first multi-site coordinated study in the field of psychotherapy.  The study 
was designed to determine what works effectively in the treatment of depression.  During 
the late 1980’s there was a growing onset of the diagnosis of depression and the need to 
determine the most viable and effective treatment.  Initially, the study wanted to clarify 
the effectiveness of each possible mode of treatment.  The study contained four modes of 
treatment:  Imipramine-CM, Placebo-CM, cognitive behavioral therapy, and 
interpersonal therapy.  This study was also the first study to directly compare two 
different forms of psychotherapy (Elkin, et al., 1989). 
     The study’s results indicated that all of the treatments were effective.  The 
Imipramine-CM was most effective, the least effective being the placebo, and the  
psychotherapies in the middle.  The two therapies were equally effective.  In follow up 
studies (Shea, 1992), results showed that there were no significant differences in relapse 
between each group, and there were no significant differences in those achieving a full 
recovery in each group. 
        In a more recent study funded by the National Institute of Mental Health, researchers 
from the University of Pennsylvania and Vanderbilt University indicate that cognitive 
therapy is at least as effective as medication for long term treatment of severe depression, 
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and it is less expensive.   DeRubeis et al., (2002) agreed that there was a need to look at 
depression from a different angle than in prior studies.  From their perspectives, prior 
studies centered on what gets people better faster.  The researchers felt that a more 
important question to ask is what will keep depression away for the long term (DeRubeis, 
et al., 2002).   
    This study involved a four-month period of acute treatment followed by an additional 
year of treatment for those who showed improvement in the initial phase.  Among those 
who continued into the second phase of the study, 75% of patients who underwent 
cognitive therapy avoided a relapse, compared to 60% of patients on medication and 19% 
of those receiving a placebo pill.  Results also showed that a brief course of cognitive 
therapy was better than a similarly brief course of medication in the year long 
continuation phase.  These results suggest that even after termination, a brief course of 
cognitive therapy may offer enduring protection (DeRubeis, et al., 2002). 
    Paykel et al., (1999) studied the effects of cognitive therapy on relapse prevention of 
residual depression.  The study indicated that depressed patients in partial remission with 
residual symptoms following anti-depressant treatment are at high risk for a complete 
relapse.  There is evidence that cognitive therapy may reduce relapse rates in depression.  
Results of the study indicated that cognitive therapy significantly reduced relapse rates 
for acute major depression and persistent and severe residual symptoms (Paykel, et al., 
1999).     
    In another study examining the economic aspects of managed care plans and 
psychotherapy treatment alternatives, a discovery was made that a new trend had been 
developing regarding the allocation of funds toward treatment research (Stoil, 1999).  In 
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his study, Stoil revealed that practitioners have long complained that managed care 
threatens the viability of psychotherapy as a treatment for mental health problems.  Stoil 
also discovered that reimbursement policies favor medication over talk therapies (Stoil, 
1999.).  Mental health clinicians argue that practice guidelines and reimbursement  
policies enforced by managed care could result in the elimination of long-term 
psychotherapy.  While conducting this research Stoil’s attention had turned to the federal 
government’s role in fostering this situation (Stoil, 1999).   Stoil suggested that Medicare 
and Medicaid policies created a model favoring drugs that offer a quick reduction of 
symptoms.  Critics had suggested that the federal government’s mental health research 
priorities might contribute to the declining support for therapy.  Very little federal money 
is offered to researchers investigating the specific psychotherapies that are effective for 
helping various types of patients.  If this trend continues the efficacy of the treatment for 
depression may be held in question.  The declining support for the continued research of 
psychotherapy when there is evidence that psychotherapy enhances treatment outcome 
supports this notion. 
        A recent study presented at the 157
th
 annual meeting of the American Psychiatric 
Association (APA) supported that psychotherapy combined with antidepressant 
medication is more effective than pharmaceutical monotherapy in treating depression 
(Moyer, 2004).  In this study 167 patients were randomized to receive either combination 
psychotherapy and antidepressant pharmacology or pharmacology alone.  Of the 
combination therapy group 72% experienced a remission of their depression symptoms 
compared with 57% of patients in the pharmacotherapy alone (Moyer, 2004).   
       Other psychiatrists who presented research at the 157
th
 meeting of the (APA) were 
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representatives of an evolving project by the APA to restore psychotherapy as a 
cornerstone of psychiatric treatment.   
        Psychiatrists noted that the research Moyer presented validates psychiatrists’ 
assumption regarding the value of combined treatment.  In particular, Dr. Barton Binder 
noted that researchers are looking at the neurobiological basis of mental conflict and 
psychotherapeutic change. He stated that brain imaging studies are helping to show the 
ways that psychotherapy improves functioning.  Binder stated that researchers want to 
integrate these findings and develop a rational understanding of the brain and the 
individual which will help clinicians deliver combined treatment more effectively 
(Moyer, 2004). 
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     CHAPTER III 
RESEARCH METHODS AND PROCEDURES 
 
Intent of the Study: 
    The intent of this study was to examine whether psychotherapy combined with 
medication compared to medication treatment alone improves treatment outcome in 
Major Depression.  This study also measured whether the groups would differ across the 
various domains of functioning within the Basis-32.  Measuring these domains would 
provide a more specific measure of symptom improvement across various areas of the 
patient’s functioning.  
Sample and Population: 
    The sample consisted of 62 adults between the ages of 27 and 56 who completed at 
least 6 months of treatment at a community mental health center in Rhode Island.  All of 
the subjects carried a diagnosis of Major Depression and were treated with medication.  
Individual therapy was available to all subjects.  The therapy involved the patient 
developing a positive supportive relationship with the therapist.  The therapy included the 
monitoring of symptoms, as well as, intervening with techniques that will interrupt 
unproductive thought patterns that may reinforce depression.  Assisting and educating 
patients to identify their own negative thought processes was of major importance for the 
development of their own personal insight.   Identifying strengths that were beneficial to 
treatment was also explored.   
     The group receiving medication and therapy will be referred to as the MT group.  The 
group receiving just medication will be referred to as the JM group.  Each group will be 
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measured for change in Basis-32 scores during the six months of treatment.  The degree 
of symptoms that were present after 6 months of treatment to the JM group will be 
referred to as JMA6M.  The degree of symptoms that were present after six months of 
treatment to the medication and therapy group will be referred to as MTA6M group.  
         Seventeen of the subjects chose to receive therapy as well as medication.  The 
remaining 45 chose just medication.  Of the seventeen who chose MT, eleven 
successfully completed the Basis-32 both during the initial phase and at the six month 
interval of treatment.  Of the remaining 45 subjects who received just medication, 26 
patients completed the Basis-32 both at the initial phase of treatment and at the six month 
interval.  Of these 26 subjects in the JM group, eleven were chosen who matched the 
eleven subjects in the MT group who had completed the Basis-32.  The groups were 
matched for age, gender and history of treatment.  No subjects within each group were 
ever hospitalized.  Each group contained eight females and three males, all between the 
ages of 34 and 47. 
Data Collection: 
      Data were gathered by acquiring the completed Basis-32 scores for subjects who 
successfully completed the scale both during the initial phase of treatment and then at the 
six month interval of treatment. 
 Hypothesis Tested: 
     Patients treated with medications and therapy compared with patients treated just with 
medication would show a significantly better treatment outcome as measured by the 
Basis-32.  
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Basis-32: 
     The Basis-32 was developed and introduced in 1994 by McLean Hospital.  The Basis-
32 is one of the most widely used outcomes measurement scales used in the United 
States.  The Basis-32 is completed at the onset of treatment and at the end of six months.  
The Basis-32 measures the change in self-reported symptoms and problem difficulty over 
the course of treatment.  The Basis-32 identifies a wide range of symptoms and problems 
that occur across the diagnostic spectrum.  The 32 refers to the first 32 questions included 
in the instrument.  These 32 questions are directly related to symptoms.  The remaining 
questions on the tool are more demographically related and non-clinical.  The Basis-32 
measures symptoms by degree of difficulty.  A score of 0 indicates no difficulty with a 
specific symptom.  A score of 4 indicates extreme difficulty with a specific symptom.  
Therefore, a lower score on the Basis-32 indicates less difficulty with symptoms.  As it 
pertains to this study, a lower score would indicate more improvement with symptoms.   
      Research indicates that the Basis-32 is an effective tool across race and culture and 
was found to be reliable.  Chun-Chung, Snowden and McConnell (2001) performed 
confirmatory factor analysis across major racial and ethnic groups of the Basis-32.  The 
results suggested acceptable levels of agreement within groups between racial and ethnic 
minority groups and whites.  The study revealed little reason to believe that the Basis-32 
varied in underlying structure across racial and ethnic boundaries (Chun-Chung, et al, 
2001).   
     In another study concerning reliability and validity, Klinkenberg, Cho, and Vieweg, 
(1998) found that the Basis-32 had good internal consistency and test-retest reliability on 
most subscales.  Subjects were randomly assigned to either a self-report or an interview 
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condition.  The study indicated that subjects rated themselves higher in the self report 
condition than in the interview condition.  Results of this study indicated that the group 
assigned to the self report condition was more internally consistent than the group 
assigned to the interview condition (Klinkenberg, et al., 1998). 
The Basis-32 is divided into five functional domains which include: 
1)  Activities of Daily Living (Questions 1-6) 
2)  Interpersonal (Questions 7-13)  
3)  Depression (Questions 14-20)  
4)  Psychosis (Questions 21-25) 
5)  Compulsivity (Questions 26-32)  
    The focus of this study emphasized the use of the Basis-32 as a whole.  The five 
domains were tested individually as well with increased focus on the depression domain 
to assess how the two groups compared with depressive symptoms.   
Methods used in Data Analysis: 
     The research was classified as Ex Post Facto.    The primary analysis was to determine 
if the two groups would differ on the mean number of improved psychiatric symptoms 
after receiving treatment at a mental health center for six months.  The clinical records for 
all subjects were reviewed to classify them into the MT or JM group.  T-tests were 
calculated to measure any differences between means for the two groups.  The t-test level 
of significance was set at .05.  A baseline analysis was completed between groups 
initially to determine if the MT and JM groups differed on their initial level of distress, a 
t-test was also run on the initial Basis-32 scores for the two groups.  An analysis within 
groups was conducted first within the JM group between initial treatment and after six 
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months.   The same analysis was conducted for the MT group.  Analysis between groups 
was conducted during the initial phase, after six months phase and then the CA6M was 
analyzed between groups.  To measure treatment outcome for each group separately a t-
test was calculated within each group comparing initial vs. after six months Basis-32 
scores.  In order to measure differences between the two groups, a between groups t-test 
was calculated to determine if one group improved more than the other.  Also, between 
groups and within group t-tests were run to determine each group’s change across the 
Basis-32 domains and then to compare changes in these domains between the JM and MT 
groups. 
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CHAPTER IV 
FINDINGS RELEVENT TO THE HYPOTHESIS 
    Findings supported the hypothesis.  The hypothesis predicted that patients treated with 
medication and therapy compared with patients treated just with medication would show 
a significantly better treatment outcome (see figure).  Results show a significant overall 
degree of improvement for both the JM and MT groups.  The study also showed a 
significant amount of improvement in three of the five domains included in the Basis-32 
for both the JM and MT groups. It is important to note that the three domains mentioned 
are directly related to the indicators of depression while the other two domains 
(Compulsivity and Psychosis are less relevant).  The three domains include Activities of 
Daily Living Skills (ADLs), Interpersonal Related Difficulties and Depression.  All three 
showed significant improvement.  
      Findings indicated that when both groups were compared initially, the groups were 
not significantly different on level of distress during the initial phase of treatment 
t(20)=.49, p>.05 (see table 1).  
Within groups: 
    When comparing the JM group’s Basis-32 pre- treatment scores with JMA6M there 
was a significant amount of improvement with symptoms t(10) =  9.83, p<.05.  When 
comparing the MT group’s pre-treatment scores with MTA6M there was also a 
significant amount of improvement with symptoms t(10) = 7.89, p<.05.   
Between groups: 
     Although both groups showed significant improvement in symptoms after treatment, 
the results reveal significantly greater improvement of symptoms or a significant 
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reduction in difficulty with symptoms for the MT group compared to the JM group after 
six months of treatment t(20) = .84, p<.05 (see table 2).   
Basis-32 Domains: 
    Results also yielded a significant degree of improvement in Activities of Daily Living 
skills, Interpersonally Related Difficulties and Depression for both groups.  When the 
domain of Activities of Daily Living Skills was compared between the JM and MT 
groups during the initial phase of treatment the t-score yielded a score of t(20) = .39, 
p>.05 indicating that these groups were not significantly different.  The t-score for the 
Interpersonal Related Difficulties between the JM and MT groups at the initial phase of 
treatment also yielded a score revealing that the groups were not significantly different 
t(20) = .34, p>.05.  The t-score for the Depression domain between the JM and MT 
groups at the initial phase of treatment revealed that both groups were not significantly 
different t(20) = .42, p>.05.    
     Although both groups showed significant improvement the MT group compared to the 
JM group showed greater improvement in all three domains.  The t-score in the domain 
of Depression for JM after 6 months of treatment compared with the initial assessment 
indicated a score of t(10) = 1.18, p<.05.  This suggested a significant decline in 
depression for the JM group after 6 months of treatment.  The t-score in the Depression 
domain for the MT group after 6 months of treatment compared with the initial 
assessment indicated a score of t(10)=.67, p<.05. This indicated a significant reduction in 
depression symptoms than the JM group.  The t-score between groups in the depression 
domain after 6 months of treatment yielded a score of t(20)= 2.10, p<.05, which indicated 
that the MT group compared to the JM group showed significantly greater improvement 
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in the Depression domain. 
       The t-score in the domain of ADLs for the JM group after 6 months of treatment 
compared with the initial assessment yielded a score of t(10)=1.36, p<.05.  This 
suggested a significant decline of difficulty with ADLs in the JM group after 6 months of 
treatment.  The t-score in the ADLs domain for the MT group compared with the initial 
assessment yielded a result of t(10)=.89, p<.05.  This indicated a significant reduction of 
symptoms with ADLs in the MT after 6 months of treatment.  The t-score between 
groups in the ADLs domain yielded a result of t(20)= 1.98, p<.05, which indicated that 
the MT group compared to the JM group showed significantly greater improvement in 
the ADLs domain after 6 months of treatment. 
   Finally, the t-score in the domain of Interpersonal Related Difficulties for the JM group 
after 6 months of treatment compared to the initial assessment yielded a score of 
t(10)=1.78, p<.05.  This suggested a significant decline in difficulty with the domain of 
interpersonal related difficulties for the JM group.  The t-score in the domain of 
Interpersonal Related Difficulties for the MT group after 6 months of treatment compared 
to the initial assessment yielded a score of t(10)=.95, p<.05.   This indicated a significant 
reduction of symptoms in the MT group after 6 months of treatment.  The t-score 
between groups in the Interpersonal Related Difficulties domain yielded a result of t 
(20)= 2.22, p<.05, which indicated that the MT group compared to the JM group showed 
significantly greater improvement in the Interpersonal Related Difficulties domain after 6 
months of treatment. 
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Table 1 
    Table one presents mean Basis-32 scores at the initial phase of treatment for adults 
receiving treatment for Major Depression who have been treated with Just Medication 
(JM) and who have been treated with Medication and Therapy (MT).  
________________________________________________________________________
________________________________________________________________________ 
 
Just Medication                                                                    Medication and Psychotherapy 
________________________________________________________________________ 
X=67.45                                                                               X= 69.18 
 
N=11                                                                                   N=11 
 
T= .49 
 
_______________________________________________________________________ 
 
P>.05 
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Table 2 
    Table two represents mean Basis-32 scores after 6 months of treatment for adults 
treated for Major Depression with Just Medication (JM) or with Medication and Therapy 
(MT). 
________________________________________________________________________
________________________________________________________________________ 
Just Medication                                                                      Medication and Therapy 
________________________________________________________________________ 
 
X= 34                                                                                         X= 19.82  
 
N= 11                                                                                          N= 11 
 
T= .84 
 
________________________________________________________________________ 
P<.05 
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Figure  
Levels of Symptom Difficulty 
 
Just Medication
Medication 6 mos. Change after 6 mos.
Meds. & Therapy
Meds. & Therapy
after 6 mos.
Change after 6 mos.
0.00
10.00
20.00
30.00
40.00
50.00
60.00
70.00
Test Scores - Change after 6 Months
Series1 67.45 34.00 33.45 69.18 19.82 49.00
1 2 3 4 5 6
 
1) Basis-32 score JM Pre-treatment : 67.45 
2) Basis-32 score JM after 6 months of treatment (A6M) : 34:00 
3) Change within group after 6 months JM (CA6M) : 33.45 
4) Basis-32 score MT Pre-treatment : 69.18 
5) Basis-32 score MT after 6 months of treatment (A6M) :19.82 
6) Change within group after 6 months (CA6M) : 49.00 
 
 
NOTE:  Higher scores reflect greater degree of symptoms. 
 
                                                       Medication versus Medication and Therapy Treatment Outcome 
  
 
 
 
 
20 
CHAPTER V 
SUMMARY OF THE STUDY 
Discussion  
     The hypothesis was supported.  It was hypothesized that adults receiving treatment for 
Major Depression with medication and therapy (MT) would show significantly greater 
improvement with their symptoms after six months of treatment than those receiving 
treatment solely with medication (JM).  By comparing the change that occurred within 
each group after 6 months of treatment (CA6M) it was clearly evident that the MT group 
showed significantly more improvement than the JM group.  As hypothesized having the 
support, direction and encouragement from psychotherapy seemed to significantly 
improve symptoms for patients receiving this added service.      
     During critical phases of treatment, the addition of therapy may be critical.  Perhaps 
the most critical phase of treatment would be during the initial six weeks where most 
anti-depressant medication trials take to reach a therapeutic level.  It is here where the 
highest distress levels are likely to be found.  Throughout treatment there are likely times 
when the added support of psychotherapy could be beneficial.   Mood swings and 
personal crisis are examples of typical struggles that occur during treatment.  Also, at the 
end of treatment patients often want to titrate off their medication as they feel strong 
enough to handle stressors without medication.  Spigset and Bjorn, (1999) summarized 
that in general no anti-depressant drug is clearly more effective than another.  If 
successful and the medications are deemed no longer necessary, a therapist can be a 
support as medications are no longer necessary.  The dose should be gradually lowered 
over several weeks before withdrawal and the therapist can provide support until the 
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patient feels prepared to disengage from treatment (Spigset & Bjorn, 1999). 
      Therapy may be helpful as a support to avoid relapse during the transition.  These 
critical phases were not taken into consideration during the analysis of this study and 
perhaps could be implications for further research.  Also, the social, family and 
environmental supports of each patient were not taken into consideration during the 
analysis of this study.  If support is sufficient in these areas, then therapy may not be 
necessary.    
        The findings of this study indicated that both groups benefited from the use of 
medication.  The MT group improved to a greater degree that the JM group and also 
improved significantly more in three of the five domains expressed in the Basis-32.  Of 
special significance would be the domain of Depression which improved most 
significantly in this study.  The depression domain symptoms are most relevant to the 
subjects studied.  A significant improvement here indicates that the subjects not only 
have benefited from the addition of therapy but have improved the circumstances of their 
diagnosis.      
Limitation of the Study: 
    Due to the small size of this group results should be cautiously interpreted.  The extent 
to which this group is generalizeable is very questionable. In this study the sample  
included adults of a lower socioeconomic scale who were already receiving treatment.  
Due to the study being ex post facto and not having within the sample a group treated 
with therapy only limits the results we will receive.  Also, this study can be difficult to 
generalize it to the CMHC due to the small sample size and lack of control.  
Implications for Further Research: 
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    There has been a fair amount of research available on the effectiveness or necessity of 
psychotherapy in the treatment of depression.  This is an important area to continue to 
research.  Focusing on the initial six weeks of treatment may be important.  It is during 
this time that patients are most distressed and more likely to be less compliant with their 
medication regimen.  It would be interesting to compare drop out rates for those receiving 
just medication versus those receiving combined treatment.    
     When patients have been successfully treated and are in remission, less intensive 
residual symptoms may continue and need to be addressed without medication.   Specific 
types of therapy could be analyzed here to rule out what may or may not be effective at 
the beginning of treatment, and also when clients are in remission.  There is much 
research studying the independent effects of medication and psychotherapy treatment for 
depression.  There is less research available that looks at combined treatment as the 
preferred treatment.  
      Research in this area could lead to more comprehensive treatment alternatives which 
include both medication and therapy in a more inclusive and strategic manner to treat 
each individual.  Perhaps it makes sense to incorporate therapy into the initial phase of 
treatment and explain the benefits it can present.  Also, to possibly educate patients with 
information about thought processes that may be counter-productive versus beneficial for 
patients while in treatment and in remission.  As indicated in studies mentioned earlier, 
the pharmacological approach appeared to be becoming the dominant mode of treatment 
research in the late 1990s.  Designs used specifically to study medications consistently 
revealed positive results which reinforced this trend.  Some changes have begun to occur 
within the American Psychiatric Association (APA) that may be leading to a more 
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balanced approach to treatment.  It is clear that both psychotherapy and medication are 
effective modes of treatment.  Which is most effective has yet to be proven.  It is likely or 
it appears that if depression is treated by both medication and therapy together, the best 
outcome may be reached.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                       Medication versus Medication and Therapy Treatment Outcome 
  
 
 
 
 
24 
References 
American Psychiatric Association.  (2000). Diagnostic and statistical manual of  
      Mental disorders (4
th
 ed., text rev.).  Washington, DC: American Psychiatric Press.    
Chun-Chung, C., Snowden, L. R., & McConnell, W. (2001).  A confirmatory 
      factor analysis of the Basis-32 in racial and ethnic samples.  The Journal of 
      Behavioral Health Services and Research, 28, 400-411.  
Corsini, R. J. (1989).  Current Psychotherapies (4th Ed.).   Itasca, IL :  F. E. Peacock. 
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., O’Reardon, J. P., Young, P.R., Shelton,  
      R. C., Solomon, R. M., & Lovett, M. L. (2002).  Cognitive therapy at least as  
      effective as drugs in treating depression.  Archives of General Psychiatry, 59, 403- 
      409. 
 Elkin, I., Shea, M. T., Watkins, J. T., Imber, S. D., Sotsky, S. M., Collins, J. F.,  
      Grass, D. R., Pilkonis, P. A., Lever, W. R., Docherty, I. P., Fiester, S. J., & 
      Parloff, M. B. (1989).  National Institute of Mental Health Treatment of  
      Depression Collaborative Research Program: General effectiveness of treatment.   
      Archives of General Psychiatry, 46, 971-982. 
Klinkenberg, W. D., Cho, D. W., & Vieweg, B. (1998).  Reliability and validity of the  
       interview and self-report versions of the BASIS-32.  Psychiatric Services, 49, 
       1229-1231.  
Moyer, P. (2004).  Combined psychotherapy, antidepressants more effective than 
       medication alone.  APA 157
th
 Annual Meeting Abstract 69B 1-2.  New York, NY. 
Paykel, E. S., Scott, J., Teasdale, J. T., Johnson, A. L., Garland, A., Moore, R.,  
       Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., & Pope, M. (1999).   
                                                       Medication versus Medication and Therapy Treatment Outcome 
  
 
 
 
 
25 
      Prevention of relapse in residual depression by cognitive therapy:  A controlled 
      trial.  Archives of General Psychiatry, 56, 829-34. 
Shea, M. T., Elkin, I., Linber, S., Sotsky, S., Watkins, J., Collins, J., Pilkonis, P., 
      Beckham, E., Glass, D., Dolan, R., & Parloff, M. (1992).  Course of 
      depressive symptoms over follow-up.  Archives of General Psychiatry, 49, 782-      
      787. 
Spigset, O., & Bjorn, M. (1999).  Drug treatment of depression.  British Medical                
      Journal.  318, 1188. 
Stoil, M. J. (1999).  Are “pills” better than “talk”?  Managed care and psychotherapy 
      treatment techniques.  Journal of Behavioral Health Management, 19, (4), 6-9.   
    
 
 
 
 
 
 
 
 
 
 
 
